NCT06707727
Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis
StatusCompleted
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 2 words
- Trial completed
- Final enrollment: 60 participants (planned 100)
- Primary completion date changed from estimate of Dec 31, 2025 to Jan 31, 2026
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
QMG changes
Timeframe: 6 months
Secondary (2)
Changes in medication type or dose
respiratory infection
Arms and interventions
myasthenia gravis
controls
Sites
1 site in 1 country
- The First Affiliated Hospital of Chongqing Medical UniversityChongqing, Chongqing Municipality, China